Galectin Therapeutics Inc (NASDAQ:GALT)

2.59
Delayed Data
As of Jul 02
 -0.03 / -1.15%
Today’s Change
2.50
Today|||52-Week Range
16.55
-25.36%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close2.62
Today’s open2.65
Day’s range2.56 - 2.65
Volume56,411
Average volume (3 months)179,405
Market cap$61.5M
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+40.00%
Earnings growth (this year)+2.56%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.80

Competitors

 Today’s
change
Today’s
% change
GBSNUGreat Basin Scientif...-0.05-0.28%
TROVUTrovagene Inc0.000.00%
TTHITransition Therapeut...+0.06+2.84%
AVDXAvant Diagnostics In...0.000.00%
Data as of 3:59pm ET, 07/02/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$0.00
Annual profit (last year)-$16.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers